* Please kindly note that our products are not to be used for therapeutic purposes and cannot be sold to patients.
MAGE-2 is an antigen recognized on a melanoma by autologous cytolytic T-lymphocytes. It reduces p53/TP53 transactivation function through recruitment of HDAC3 to p53/TP53 transcription sites.
